Filing Details
- Accession Number:
- 0000891293-16-000113
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-03-04 18:30:33
- Reporting Period:
- 2016-03-04
- Filing Date:
- 2016-03-04
- Accepted Time:
- 2016-03-04 18:30:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 891293 | Cti Biopharma Corp | CTIC | Pharmaceutical Preparations (2834) | 911533912 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1557551 | Matthew Plunkett | 3101 Western Avenue, Suite 600 Seattle WA 98121 | Evp, Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2016-03-04 | 1,300 | $0.59 | 598,784 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-03-04 | 400 | $0.59 | 598,384 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-03-04 | 636 | $0.59 | 597,748 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-03-04 | 1,500 | $0.59 | 596,248 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-03-04 | 844 | $0.59 | 595,404 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-03-04 | 700 | $0.59 | 594,704 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-03-04 | 700 | $0.59 | 594,004 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-03-04 | 200 | $0.59 | 593,804 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-03-04 | 1,100 | $0.59 | 592,704 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-03-04 | 500 | $0.59 | 592,204 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-03-04 | 1,220 | $0.60 | 590,984 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-03-04 | 900 | $0.60 | 590,084 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sale was effected pursuant to a Rule 10b5-1 trading plan.
Billionaire Hedge Funds
